Recon: Abbott beats quarterly profit estimates; UK approves Penlon ventilator for COVID-19

• Chaotic search for coronavirus treatments undermines efforts, experts say (Washington Post)
• House Speaker Pelosi calls Trump WHO decision senseless, dangerous (Reuters)
• Trump Admin. Officials Warned Against Halting Funding to WHO - Leaked Memo (ProPublica)
• White House snubs Azar, installs Trump loyalist Michael Caputo as HHS spokesperson (Politico)
• House Progressives Seek to Bar Vaccine, Treatment Exclusivity (Bloomberg) (Law360)
• US Senate Democrats seek $30 billion for national coronavirus testing (Reuters)
• Americans aren't ready to go back to normal after a coronavirus reopening (Axios) (Reuters)
• Testing Falls Woefully Short as Trump Seeks an End to Stay-at-Home Orders (NYTimes)
• US races to stock up on dialysis supplies as kidney failure ravages virus patients (Politico)
• Sanofi teams up with US firm Luminostics on developing COVID-19 testing app (Reuters)
• FDA Grants Approval of Jelmyto to Urogen Pharma (Bloomberg Law) (Endpoints) (FDA) (Press)
• Gilead is Said to Hold Arcus Stake Talks, Spurring 54% Rally (Bloomberg) (Endpoints)
• Biogen joins consortium for building COVID-19 'biobank' (Reuters)
• Abbott beats quarterly profit, but pulls forecast on coronavirus concerns (Reuters)
• Half of prescriptions needed for Covid-19 patients on ventilators are going unfilled (STAT)

• 'We Alerted The World' To Coronavirus On Jan. 5, WHO Says In Response To US (NPR) (NYTimes)
• Europe coronavirus cases reach almost 1 million, coming weeks 'critical': WHO (Reuters)
• Japan, China Vie to Be Global Supplier of Unproven Coronavirus Drug (WSJ)
• Aurobindo’s regulatory woes cast a shadow on strong fundamentals (Economic Times)
• Aid groups ask UK gov to stop pharma 'profiteering' from COVID-19 (PharmaTimes)
• Canadian hospitals prepare to sterilize, re-use N95 masks if supplies dwindle (Reuters)
• Penlon ventilator receives UK approval in battle against coronavirus (Reuters)
• Israel retrofits home-use respirators into ventilators to treat coronavirus (Reuters)
• Gilead Japan to Seek Early Remdesivir Filing If Initial Data Prove Positive: Development Chief (PharmaJapan)
• PMDA: Novartis’ Flawed, Delayed Responses in Zolgensma Review ‘Extremely Unusual’ (PharmaJapan)

• Coronavirus Vaccine Prospects (In the Pipeline)
• Fauci: Coronavirus vaccines could be ready sooner than expected (Axios)
• Coronavirus: Drugs to be tested on lungs of ICU patients (BBC)
• Roivant begins giving experimental COVID-19 drug to first US patients (Reuters)
• Coronavirus pandemic threatens to take crushing toll on rural areas, data show (STAT)
• Private labs say demand for coronavirus tests is down and they can test more people who aren't as sick (NBC)
• Here’s What We Know about the Most Touted Drugs Tested for COVID-19 (Scientific American)
• Scientists tap CRISPR’s search-and-detect skills to create a rapid Covid-19 test (STAT)
• Blood clots in severe Covid-19 patients leave clinicians with clues about the illness — but no proven treatments (STAT)
• Simply speaking could transmit coronavirus, new study suggests (STAT) (NEJM)
• Gay men still unable to donate blood and plasma despite new FDA guidelines. Here's why. (NBC)
• US coronavirus deaths increase by record amount for second straight day: Reuters tally (Reuters)
• US coronavirus deaths march higher to over 31,000: Reuters tally (Reuters)
• The CDC and WHO Have Already Said Mosquitoes Don’t Spread Coronavirus. Now USDA Will Study It, Too. (ProPublica)
• Australia to retain coronavirus curbs for at least another four weeks (Reuters)
• Germany plans partial reopening of shops and schools: sources (Reuters)
• Britain probably reaching virus peak, says England's Chief Medical Officer (Reuters)
• French coronavirus toll jumps by record 1,438 deaths (Reuters)
• Australia to keep coronavirus restrictions for four more weeks despite success (Reuters)
• As Brazil's COVID-19 testing lags, available labs go unused (Reuters)
• Supplies for coronavirus field hospital held up at US-Mexico border (Reuters)
• Mexico president says UN slow in ensuring access to medical gear amid coronavirus (Reuters)
• Coronavirus (COVID-19) Update: Daily Roundup April 15, 2020 (FDA)

• Is It Safe to Take That Medication While Breastfeeding? (NYTimes)
• Remarks by Dr. Hahn to the 2020 Rx Drug Abuse and Heroin Summit (FDA)
• Leo Pharma licenses global rights from two Asian biotechs (PMLive)
• Sumitomo subsidiary flashes new way of treating schizophrenia in PhII trial (Endpoints) (Science Mag)
• Evidence from Pragmatic Trials during Routine Care — Slouching toward a Learning Health System (NEJM)
• Amneal yanks ulcer drug off US shelves on fears of carcinogen contamination (Fierce)
• Delayed Advisory Committees Need Not Worry Sponsors Too Much (Pink Sheet)
• Regeneron gets FDA priority review for Ebola sibling of COVID-19 prospect (Fierce)
• Covid medicine: Dr Reddy’s Laboratories begins work on Gilead drug clone (Economic Times)
• Novo Nordisk expands 90-day free insulin program to workers affected by COVID-19 (Fierce)
• CARES Act Will Accelerate OTC Drug Development (Law360)
• Drug Cos. May Find Real-World Evidence Cuts Both Ways (Law360)
• Abundant funding, sparse data: San Francisco startup backs 'real world' model for rare disease drug development (Endpoints)
• Interim data on Vir's Alnylam-partnered RNAi hep B drug suggest efficacy is broadly on par with J&J, Arrowhead rival — analysts (Endpoints)
• Pascal Soriot, lamenter of low pay, faces investor revolt for being overcompensated (Endpoints)
• Galapagos finds Polish partner for inflammation drugs; Zai Lab's Zejula app gets speedy review in China (Endpoints)
• Top FDA Drug Compliance Concerns during 2019 Included OTCs, Supply Chain Information Flow, Compounding, and Genotoxic Impurities (IPQ)
• The European research-based pharmaceutical industry’s commitment to tackling the coronavirus pandemic (EFPIA)

• Boston Scientific to begin selling cheaper ventilator alternative (MedtechDive)
• Philips launches scaled-down ventilator, inks production deals to boost output (MedtechDive)
• Dexcom gets FDA permission to use continuous glucose monitors on hospitalized COVID-19 patients (San Diego Union-Tribune)
• CMS doubles Medicare payment for coronavirus diagnostic lab tests (MedtechDive)

• Pharmacy chains gain a ‘solid’ victory in opioid litigation, but aren’t off the hook yet (STAT)
• Utah bill would clear the way for experimental drugs to treat COVID-19 (Salt Lake Tribune)
• Pandemic will delay blockbuster trial of ex-Theranos CEO Elizabeth Holmes (STAT) (CNBC)
• PTAB Axes University Of Chicago Cancer Treatment Patent (Law360)
• Federal Court of Australia grants interim injunction to prevent advertising by Evolution Supplements Australia (TGA)
• Medical device labelling obligations (TGA)
• Regulation of Personal Protective Equipment and COVID-19 (TGA)